MEK1 Derived Peptide Inhibitor 1 is a biomedical product used for treating cancer by specifically targeting the MEK1 enzyme. This inhibitor peptide effectively blocks the activation of MEK1, a critical protein involved in cancer cell growth and proliferation. Its high specificity ensures minimal off-target effects, making it a promising candidate for cancer therapy.
CAT# | GR2210 |
CAS | 355367-87-2 |
M.F/Formula | C68H118N18O17S |
M.W/Mr. | 1491.84 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PBP 10 (RhoB-Glu-Arg-Leu-Phe-Glc-Val-Lys-Glc-Arg-Arg) is a 10-aa-long rhodamine-linked and membrane-permeable pe ...
Figure 1. Chemical structure of lysipressinLysipressin ([Lys8]-vasopressin) has been identified in the North Ame ...
Gonadorelin is a synthetic GnRH, a peptide compound, and a decapeptide whose structure is exactly the same as th ...
PMX-53, a chemically synthesized peptide material, is a potent C5a antagonist in human neutrophils and macrophag ...
DAMME (DA) is a guanine, often referred to as FK 33-824 (FK), which is a long-acting enkephalin analog. Natur ...